These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 35038132)
41. Is airway inflammation in chronic obstructive pulmonary disease (COPD) a risk factor for cardiovascular events? Calverley PM; Scott S COPD; 2006 Dec; 3(4):233-42. PubMed ID: 17361504 [TBL] [Abstract][Full Text] [Related]
42. Does low vitamin D amplify the association of COPD with total and cardiovascular disease mortality? Lee HM; Liu M; Lee K; Luo Y; Wong ND Clin Cardiol; 2014 Aug; 37(8):473-8. PubMed ID: 24719373 [TBL] [Abstract][Full Text] [Related]
43. Advances in understanding of mechanisms related to increased cardiovascular risk in COPD. Rogliani P; Ritondo BL; Laitano R; Chetta A; Calzetta L Expert Rev Respir Med; 2021 Jan; 15(1):59-70. PubMed ID: 33084434 [TBL] [Abstract][Full Text] [Related]
44. [COPD and heart disease]. Watz H; Arzt M Herz; 2014 Feb; 39(1):53-7. PubMed ID: 24509868 [TBL] [Abstract][Full Text] [Related]
45. Peripheral arterial disease in patients with chronic obstructive pulmonary disease. Pecci R; De La Fuente Aguado J; Sanjurjo Rivo AB; Sanchez Conde P; Corbacho Abelaira M Int Angiol; 2012 Oct; 31(5):444-53. PubMed ID: 22990507 [TBL] [Abstract][Full Text] [Related]
46. Increased risk for cardiovascular disease in patients with obstructive sleep apnoea syndrome-chronic obstructive pulmonary disease (overlap syndrome). Voulgaris A; Archontogeorgis K; Papanas N; Pilitsi E; Nena E; Xanthoudaki M; Mikhailidis DP; Froudarakis ME; Steiropoulos P Clin Respir J; 2019 Nov; 13(11):708-715. PubMed ID: 31433558 [TBL] [Abstract][Full Text] [Related]
47. Association of lung function with cardiovascular risk: a cohort study. Wang B; Zhou Y; Xiao L; Guo Y; Ma J; Zhou M; Shi T; Tan A; Yuan J; Chen W Respir Res; 2018 Nov; 19(1):214. PubMed ID: 30400894 [TBL] [Abstract][Full Text] [Related]
48. Independent risk factors for mortality in patients with chronic obstructive pulmonary disease who undergo comprehensive cardiac evaluations. Ahn YH; Lee KS; Park JH; Jung JH; Lee M; Jung YJ; Chung WY; Sheen S; Park KJ; Kim DJ; Kang DR; Lee JD; Yoon S; Jin XJ; Yang HM; Lim HS; Park JS; Shin JH; Tahk SJ Respiration; 2015; 90(3):199-205. PubMed ID: 26278777 [TBL] [Abstract][Full Text] [Related]
49. Chronic obstructive pulmonary disease severity and cardiovascular outcomes. Curkendall SM; Lanes S; de Luise C; Stang MR; Jones JK; She D; Goehring E Eur J Epidemiol; 2006; 21(11):803-13. PubMed ID: 17106760 [TBL] [Abstract][Full Text] [Related]
50. Cardiovascular Outcomes and All-Cause Mortality in Patients with Obstructive Sleep Apnea and Chronic Obstructive Pulmonary Disease (Overlap Syndrome). Kendzerska T; Leung RS; Aaron SD; Ayas N; Sandoz JS; Gershon AS Ann Am Thorac Soc; 2019 Jan; 16(1):71-81. PubMed ID: 30372124 [TBL] [Abstract][Full Text] [Related]
51. Endothelial function in patients with chronic obstructive pulmonary disease: a systematic review of studies using flow mediated dilatation. Vaes AW; Spruit MA; Theunis J; Goswami N; Vanfleteren LE; Franssen FME; Wouters EFM; De Boever P Expert Rev Respir Med; 2017 Dec; 11(12):1021-1031. PubMed ID: 28978239 [TBL] [Abstract][Full Text] [Related]
52. Measuring cardiovascular risk in COPD; child's play or MENSA? Rothnie KJ; Quint JK Chron Respir Dis; 2016 Aug; 13(3):209-10. PubMed ID: 27282850 [No Abstract] [Full Text] [Related]
53. Exacerbations of Chronic Obstructive Pulmonary Disease and Cardiac Events. A Post Hoc Cohort Analysis from the SUMMIT Randomized Clinical Trial. Kunisaki KM; Dransfield MT; Anderson JA; Brook RD; Calverley PMA; Celli BR; Crim C; Hartley BF; Martinez FJ; Newby DE; Pragman AA; Vestbo J; Yates JC; Niewoehner DE; Am J Respir Crit Care Med; 2018 Jul; 198(1):51-57. PubMed ID: 29442524 [TBL] [Abstract][Full Text] [Related]
54. Relation of Chronic Obstructive Pulmonary Disease to Cardiovascular Disease in the General Population. Song S; Yang PS; Kim TH; Uhm JS; Pak HN; Lee MH; Joung B Am J Cardiol; 2017 Oct; 120(8):1399-1404. PubMed ID: 28826898 [TBL] [Abstract][Full Text] [Related]
55. Fluticasone Furoate, Vilanterol, and Lung Function Decline in Patients with Moderate Chronic Obstructive Pulmonary Disease and Heightened Cardiovascular Risk. Calverley PMA; Anderson JA; Brook RD; Crim C; Gallot N; Kilbride S; Martinez FJ; Yates J; Newby DE; Vestbo J; Wise R; Celli BR; Am J Respir Crit Care Med; 2018 Jan; 197(1):47-55. PubMed ID: 28737971 [TBL] [Abstract][Full Text] [Related]
56. Profile of Cardiovascular Disease Patients Who are Diagnosed with COPD in a Smoking-Cessation Unit. Riesco JA; Hidalgo M; Chipayo D; Gómez JJ; Zaragozá F Adv Ther; 2020 Aug; 37(8):3562-3570. PubMed ID: 32588373 [TBL] [Abstract][Full Text] [Related]
57. COPD and incident cardiovascular disease hospitalizations and mortality: Kaiser Permanente Medical Care Program. Sidney S; Sorel M; Quesenberry CP; DeLuise C; Lanes S; Eisner MD Chest; 2005 Oct; 128(4):2068-75. PubMed ID: 16236856 [TBL] [Abstract][Full Text] [Related]
58. Endothelial dysfunction assessment by noninvasive peripheral arterial tonometry in patients with chronic obstructive pulmonary disease compared with healthy subjects. Malerba M; Radaeli A; Nardin M; Clini E; Carpagnano GE; Sciatti E; Salghetti F; Bonadei I; Platto F; Vizzardi E Clin Respir J; 2018 Apr; 12(4):1466-1472. PubMed ID: 28779547 [TBL] [Abstract][Full Text] [Related]
59. Cardiovascular risk, chronic obstructive pulmonary disease and pulmonary rehabilitation: Can we learn from cardiac rehabilitation? Triest FJ; Singh SJ; Vanfleteren LE Chron Respir Dis; 2016 Aug; 13(3):286-94. PubMed ID: 27081189 [TBL] [Abstract][Full Text] [Related]